Ralph Zinner
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 33
- Lung Cancer Diagnosis and Treatment 18
- Oncology 33
- Lung Cancer Research Studies 14
- HER2/EGFR in Cancer Research 6
- Co-authors
- David S. Hong (40 shared papers)Filip Jankú (34 shared papers)Jennifer J. Wheler (35 shared papers)Apostolia Maria Tsimberidou (33 shared papers)Siqing Fu (36 shared papers)Aung Naing (31 shared papers)Razelle Kurzrock (32 shared papers)Sarina Anne Piha-Paul (35 shared papers)
- Journals
- Oncotarget (11 papers)Clinical Cancer Research (9 papers)Annals of Oncology (8 papers)Investigational New Drugs (8 papers)Journal of Thoracic Oncology (8 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Ralph Zinner
115 papers receiving 4.4k citations
Ralph Zinner's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.6k
- Cancer Research 835
- Pulmonary and Respiratory Medicine 1.3k
- Otorhinolaryngology 127
- Pathology and Forensic Medicine 398
Countries citing papers authored by Ralph Zinner
This map shows the geographic impact of Ralph Zinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Zinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Zinner more than expected).
Fields of papers citing papers by Ralph Zinner
This network shows the impact of papers produced by Ralph Zinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Zinner. The network helps show where Ralph Zinner may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph Zinner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications Hit paper breakdown → | 2014 | 381 |
| 2 | 2002 | 284 | |
| 3 | 1999 | 277 | |
| 4 | 2014 | 212 | |
| 5 | 2016 | 197 | |
| 6 | 2004 | 144 | |
| 7 | 2014 | 135 | |
| 8 | 2003 | 109 | |
| 9 | 2016 | 89 | |
| 10 | 2009 | 86 | |
| 11 | 2015 | 86 | |
| 12 | 2015 | 84 | |
| 13 | 1995 | 82 | |
| 14 | 2005 | 80 | |
| 15 | 2002 | 79 | |
| 16 | 2005 | 78 | |
| 17 | 2014 | 72 | |
| 18 | 2016 | 72 | |
| 19 | 2006 | 60 | |
| 20 | 2017 | 58 |
About Ralph Zinner
Ralph Zinner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Otorhinolaryngology, having authored 118 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Research Studies (14 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Genomics and Diagnostics (7 papers), HER2/EGFR in Cancer Research (6 papers), Melanoma and MAPK Pathways (6 papers) and Head and Neck Cancer Studies (5 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (835 citations), Pulmonary and Respiratory Medicine (1.3k citations), Otorhinolaryngology (127 citations) and Pathology and Forensic Medicine (398 citations). Ralph Zinner has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include David S. Hong, Filip Jankú, Jennifer J. Wheler, Apostolia Maria Tsimberidou, Siqing Fu, Aung Naing, Razelle Kurzrock, Sarina Anne Piha-Paul, Gerald Steven Falchook and Vivek Subbiah. Their work appears in journals such as Oncotarget, Clinical Cancer Research, Annals of Oncology, Investigational New Drugs and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.